| answer text |
<p>The ownership of intellectual property (IP) arising from publicly funded research
in the UK, including from Medical Research Council (MRC), resides with the research
organisation within which the research is undertaken; which could be a university,
independent research organisation or research council institute. These research organisations
are expected to have exploitation arrangements in place as a condition of the transfer
of IP ownership (for example, in Research Council grants), to enable third parties,
including businesses and other organisations, to licence or commercialise the results
of this research.</p><p>Where research is conducted in an MRC owned unit or institute,
the arising IP is owned by the MRC. MRC uses LifeArc as its “technology transfer agent”
for the protection, management and exploitation of this IP, including licencing to
business and other organisations. Royalties arising from these licensing activities,
and from licensing to any spin-outs based on any MRC-owned IP, are owned by the MRC
for as long as the patent is effective; the earned income is re-invested by MRC in
research.</p>
|
|
